ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $810,000 | -22.6% | 19,565 | +11.6% | 0.06% | -22.6% |
| Q2 2022 | $1,046,000 | -10.4% | 17,530 | +9.0% | 0.08% | +44.8% |
| Q1 2022 | $1,168,000 | -60.1% | 16,084 | -53.8% | 0.06% | -58.6% |
| Q4 2021 | $2,927,000 | +265.4% | 34,806 | +292.1% | 0.14% | +97.2% |
| Q3 2021 | $801,000 | -17.8% | 8,876 | -13.2% | 0.07% | -15.5% |
| Q2 2021 | $975,000 | -17.2% | 10,225 | -1.1% | 0.08% | -25.0% |
| Q1 2021 | $1,177,000 | -28.8% | 10,334 | -13.5% | 0.11% | -35.3% |
| Q4 2020 | $1,653,000 | +79.3% | 11,942 | +6.5% | 0.17% | +53.1% |
| Q3 2020 | $922,000 | +9.6% | 11,212 | +4.3% | 0.11% | +0.9% |
| Q2 2020 | $841,000 | +108.2% | 10,749 | +18.3% | 0.11% | +51.4% |
| Q1 2020 | $404,000 | -77.1% | 9,090 | -78.0% | 0.07% | -72.9% |
| Q4 2019 | $1,762,000 | +10.7% | 41,249 | +10.9% | 0.27% | -0.4% |
| Q3 2019 | $1,591,000 | -51.8% | 37,200 | -28.5% | 0.27% | -40.4% |
| Q2 2019 | $3,302,000 | -35.1% | 52,000 | -29.1% | 0.46% | -27.6% |
| Q1 2019 | $5,084,000 | +64.5% | 73,300 | +3.1% | 0.64% | +70.7% |
| Q4 2018 | $3,091,000 | -51.2% | 71,100 | -14.3% | 0.37% | -38.4% |
| Q3 2018 | $6,336,000 | +25.1% | 83,000 | +25.9% | 0.60% | +17.7% |
| Q2 2018 | $5,066,000 | -7.0% | 65,900 | -38.3% | 0.51% | -1.9% |
| Q1 2018 | $5,448,000 | +9.9% | 106,850 | 0.0% | 0.52% | +13.0% |
| Q4 2017 | $4,956,000 | -27.5% | 106,850 | -16.7% | 0.46% | -18.5% |
| Q3 2017 | $6,834,000 | -11.5% | 128,320 | +3.2% | 0.57% | -14.8% |
| Q2 2017 | $7,722,000 | +6.0% | 124,320 | +15.7% | 0.67% | +6.2% |
| Q1 2017 | $7,283,000 | +14.1% | 107,450 | +18.4% | 0.63% | +7.4% |
| Q4 2016 | $6,381,000 | +5.5% | 90,750 | +6.5% | 0.58% | +14.3% |
| Q3 2016 | $6,048,000 | – | 85,250 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |